Association of HLA class II genes with systemic sclerosis in Spanish patients

Journal of Rheumatology

Volumn 36, Issue 12, 2009, Pages 2733-2736

  Simeón, Carmen P ^a   Fonollosa, Vicent ^a   Tolosa, Carles ^b   Palou, Eduard ^a   Selva, Albert ^a   Solans, Roser ^a   Armadans, Lluis ^a   Moreno, Estefania ^a   Marsal, Sara ^a   Vilardell, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

Author keywords

Autoantibodies; Clinical subsets; HLA; Pulmonary involvement; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; GENETIC SUSCEPTIBILITY; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SPAIN; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; ALLELES; AUTOANTIBODIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 72449202314     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090377     Document Type: Article

References (17)

1. Gladman D, Kung T, Siannis F, Pellett F, Farewell VT, Lee P. HLA markers for susceptibility and expression in scleroderma. J Rheumatol 2005;32:1481-1487 (Pubitemid 41113968)
2. Kuwana M, Kaburiaki J, Okano Y, Inoko H, Tsuji K. HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 1993;92:1296-1301 (Pubitemid 23273905)
3. Tan FK, Stivers DN, Arnett FC, Chakraborty R, Howard R, Reveille JD. HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma. Tissue Antigens 1999;53:74-80. (Pubitemid 29084176)
4. Reveille JD, Fischbach M, McNearny T, Friedman AW, Aquilar MB, Lisse J, et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic and immunogenetic determinants. Semin Arthritis Rheum 2001;30:332-346 (Pubitemid 32298859)
5. Frezza D, Giambra V, Tolusso B, De Santis M, Bosello S, Vettori S, et al. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann Rheum Dis 2007;66:1210-1215
6. Loubiere LS, Lambert NC, Madeleine MM, Porter AJ, Mullarkey ME, Panq JM, et al. HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women. Rheumatology 2005;44:318-322
7. Langevitz P, Buskila D, Gladman DD, Darlington GA, Farewell VT, Lee P. HLA alleles in systemic sclerosis: association with pulmonary arterial hypertension and outcome. Br J Rheumatol 1992;31:609-613
8. Fanning GC, Welsh KI, Bunn C, Du Bois R, Black CM. HLA associations in 3 mutually exclusive autoantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol 1998;37:201-217
9. Reveille JD, Durban E, MacLeod-St. Clair MJ, Goldstein R, Moreda R, Altman RD, et al. Association of amino acid sequence in HLA-DQB1 first domain with the antitopoisomerase I autoantibodies response in scleroderma. J Clin Invest 1992;90:973-980
10. Takeuchi F, Nakano K, Yamada H, Hong GH, Nabeta H, Yoshida A, et al. Association of HLA-DR with progressive systemic sclerosis in Japanese. J Rheumatol 1994;21:857-863 (Pubitemid 24168669)
11. Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, et al. Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 1996;39:1362-1370
12. Vlachoyiannopoulos PG, Dafni UG, Pakas I, Spyropoulou-Vlachou M, Stavropoulos-Giokas C, Moutsopoulos HM. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104. Ann Rheum Dis 2000;59:359-367
13. Morel PA, Chang HJ, Wilson JW, Conte C, Falkner D, Tweardy DJ, et al. HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies. Hum Immunol 1995;42:35-42.
14. Kuwana M, Okano Y, Kaburaki J, Inoko H. HLA class II genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (scleroderma). Ann Rheum Dis 1995;54:983-987
15. Reveille JD, Durban E, Goldstein R, Moreda R, Arnett FC. Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum 1992;35:216-218
16. Simeon CP, Armadans L, Fonollosa V, Vilardell M, Candell J, Tolosa C, et al. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis. Ann Rheum Dis 1997;56:723-728 (Pubitemid 28064838)
17. Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, et al. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 2003;42:71-75 (Pubitemid 36131570)